(TRAK) ReposiTrak - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7002153044
TRAK: Software, Supply Chain, Compliance, Traceability, E-commerce, Consulting
ReposiTrak, Inc. (NASDAQ:TRAK), a SaaS provider, offers a suite of proprietary software solutions tailored for the retail and supply chain sectors in North America. Their platform includes ReposiTrak MarketPlace, which facilitates supplier discovery and B2B e-commerce through streamlined digital interactions. The Compliance and Food Safety solutions mitigate regulatory risks by automating compliance tracking and monitoring, ensuring adherence to food safety standards. Additionally, their Supply Chain solutions enhance supplier relationship management through improved communication and process optimization. The Traceability Network captures critical product data, enabling precise tracking and recall management. The company also provides consulting services to retailers and suppliers across grocery, convenience, and specialty sectors, focusing on operational efficiency and compliance. Headquartered in Murray, Utah, ReposiTrak, formerly Park City Group, rebranded in December 2023. They have partnered with Upshop to enhance grocery retail traceability.
From a technical standpoint, TRAKs average 20-day volume is 45,556, with a last price of $18.98. The SMA20 at $20.76 and SMA50 at $21.52 suggest a bearish trend below these moving averages. The ATR of 0.81 indicates low volatility, signaling stable price movements. Fundamentally, with a market cap of $391.20M, TRAKs high P/E of 73.93 and P/B of 8.04 may indicate overvaluation, despite a positive RoE of 13.24. The P/S ratio of 17.79 reflects strong revenue per share.
3-Month Forecast: TRAK is expected to trade sideways to slightly down, influenced by its position below key SMAs. Support may be found near $18.50, with resistance at $21.00. The low ATR suggests minimal price fluctuations, likely ranging between $18.00 and $20.00. While the companys strong market position and partnerships are positives, high valuations may lead to a correction, making the stock sensitive to broader market movements.
Additional Sources for TRAK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRAK Stock Overview
Market Cap in USD | 391m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Application Software |
IPO / Inception | 1998-11-19 |
TRAK Stock Ratings
Growth Rating | 84.6 |
Fundamental | 66.1 |
Dividend Rating | 43.5 |
Rel. Strength | 20 |
Analysts | 4/5 |
Fair Price Momentum | 22.56 USD |
Fair Price DCF | 12.38 USD |
TRAK Dividends
Dividend Yield 12m | 0.17% |
Yield on Cost 5y | 0.91% |
Annual Growth 5y | 49.38% |
Payout Consistency | 66.4% |
TRAK Growth Ratios
Growth Correlation 3m | -72.8% |
Growth Correlation 12m | 79.2% |
Growth Correlation 5y | 84.4% |
CAGR 5y | 40.32% |
CAGR/Max DD 5y | 0.78 |
Sharpe Ratio 12m | -0.28 |
Alpha | 13.48 |
Beta | 0.785 |
Volatility | 62.61% |
Current Volume | 73.5k |
Average Volume 20d | 62.1k |
As of April 11, 2025, the stock is trading at USD 19.84 with a total of 73,526 shares traded.
Over the past week, the price has changed by +6.32%, over one month by +1.33%, over three months by -4.25% and over the past year by +14.72%.
Yes, based on ValueRay Fundamental Analyses, ReposiTrak (NASDAQ:TRAK) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.05 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRAK as of April 2025 is 22.56. This means that TRAK is currently undervalued and has a potential upside of +13.71% (Margin of Safety).
ReposiTrak has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TRAK.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TRAK ReposiTrak will be worth about 24.9 in April 2026. The stock is currently trading at 19.84. This means that the stock has a potential upside of +25.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 24 | 21% |
Analysts Target Price | 24 | 21% |
ValueRay Target Price | 24.9 | 25.6% |